News Roundup [abridged Versions Appear In The Paper Journal]

Depo-Provera contraceptive may increase risk of cardiovascular disease

BMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7363.513 (Published 07 September 2002) Cite this as: BMJ 2002;325:513
  1. Xavier Bosch
  1. Barcelona

    The long acting contraceptive Depo-Provera (depot medroxyprogesterone acetate, DMPA) may increase the risk of heart disease in women taking the drug for more than a year, new research has suggested.

    The study, due to be published on 17 September in Circulation, the journal of the American Heart Association, and already available on line (www.circ.ahajournals.org/), shows that the contraceptive can impair arterial responsiveness to increased blood flow as a result of endothelial cell abnormality.

    Lead author Professor Dudley Pennell of the Royal Brompton Hospital, London, …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe